§ Federal grant opportunity · HT942526AZRPTRDA
DoW Alzheimer’s Transforming Diagnosis Award
JoAnn Martin Grantor is accepting applications for DoW Alzheimer’s Transforming Diagnosis Award. The deadline is September 24, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- JoAnn Martin Grantor
- Application deadline
- September 24, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526AZRPTRDA
Program overview
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. Distinctive Features: Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required. Community collaboration is required for studies prospectively enrolling human subjects. Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from JoAnn Martin Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 24, 2026, allowing time for registration and validation.
Related grant opportunities
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
- FY26 Bureau of Land Management Invasive and Noxious Plant Management - Bureau wide
- National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
- Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
- ROSES25: B.2 Heliophysics Foundational Research
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.